Arrive AI Announces First Quarter 2026 Results and Highlights Operational Progress Toward Commercial Scale
The company will host a conference call and webcast today at
"We continue to believe our most important metric right now is operational progress and milestone achievement," said Founder and CEO
Recent Operational Highlights
During the quarter,
-
Expanded and stabilized manufacturing operations through a new manufacturing partnership in
India for the AP3, the company's currentArrive Point model.
-
Remained on track for an improved AP3 release in July, with broader availability expected beginning in October
-
Continued development of its next-generation APX platform
-
Advanced Arrive OS, the company's internally developed operating system and deployment software layer
-
Fully internalized software development operations to improve efficiency and reduce third-party costs
-
Continued preparations for a digital demonstration initiative planned for
Texas later this year
-
Expanded its patent portfolio to 10 U.S. utility patents
-
Held its first Board meeting with newly appointed director
Mike Fitz of T-Mobile for Business
Q1 2026 Financial Highlights
-
Revenue of approximately
$14,925 , consisting entirely of recurring subscription revenue
-
Net loss of approximately
$6.4 million , compared to approximately$2 million in Q1 2025
-
Approximately
$5.7 million in cash and$2.8 million in short-term investments at quarter end
-
Quarterly operating cash outflow of approximately
$3 million , primarily related to team expansion and infrastructure development
The company also announced it recently reached a standstill agreement with
"As we continue executing, our focus remains straightforward: strengthen the platform, expand deployments, improve scalability, and maintain discipline on capital allocation, positioning
Earnings Call Details:
-
Title:
Arrive AI Inc. Q1 2026 Earnings Call
-
Date:
May 15, 2026
-
Time:
8:30 AM EDT (Live Event)
-
Duration: 60 minutes
-
Webcast Link: https://edge.media-server.com/mmc/p/4ovfitm5.
If you are an analyst and would like to join the call to ask questions, please contact Alliance IR at ARAI.IR@allianceadvisors.com.
A replay of the call will be available after the event on
Following opening remarks from Founder and CEO
About
Media Contact
media@arriveai.com
Investor Relations Contact
Alliance Advisors IR
ARAI.IR@allianceadvisors.com
Cautionary Note Regarding Forward-Looking Statements
This news release and statements of
Forward-looking statements relate to future events and expected business and financial performance and often include words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic," or "may," and similar expressions.
These statements are based on information available as of the date of this release and reflect management's current views and assumptions. They are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors that may be beyond the company's control.
Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this release. Potential investors should review
CONDENSED BALANCE SHEETS
|
|
|
|
|
|
|
|
||
|
|
|
(Unaudited) |
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
ASSETS
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
CURRENT ASSETS
|
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
|
$ |
5,667,553 |
|
|
$ |
2,104,004 |
|
|
Investments at fair value
|
|
|
2,802,060 |
|
|
|
- |
|
|
Accounts receivable, net of allowance
|
|
|
- |
|
|
|
4,975 |
|
|
Prepaid expenses
|
|
|
280,102 |
|
|
|
189,878 |
|
|
Other current assets
|
|
|
12,325 |
|
|
|
12,325 |
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
8,762,040 |
|
|
|
2,311,182 |
|
|
|
|
|
|
|
|
|
|
|
|
OTHER ASSETS
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
679,333 |
|
|
|
514,684 |
|
|
Right of use assets - operating leases
|
|
|
2,023,420 |
|
|
|
2,117,284 |
|
|
Patents, net of accumulated amortization of
|
|
|
271,580 |
|
|
|
272,097 |
|
|
Deferred offering costs
|
|
|
3,475,514 |
|
|
|
5,650,185 |
|
|
Other assets
|
|
|
279,187 |
|
|
|
65,633 |
|
|
|
|
|
|
|
|
|
|
|
|
Total other assets
|
|
|
6,729,034 |
|
|
|
8,619,883 |
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS
|
|
$ |
15,491,074 |
|
|
$ |
10,931,065 |
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
227,909 |
|
|
$ |
183,993 |
|
|
Accrued expenses
|
|
|
1,490,720 |
|
|
|
538,234 |
|
|
Operating lease liability
|
|
|
408,345 |
|
|
|
392,950 |
|
|
Derivative liabilities
|
|
|
1,440,000 |
|
|
|
1,460,000 |
|
|
Convertible note payable, net of discount and debt issuance costs of
|
|
|
7,681,354 |
|
|
|
4,144,657 |
|
|
Note payable
|
|
|
8,336 |
|
|
|
9,140 |
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
11,256,664 |
|
|
|
6,728,974 |
|
|
|
|
|
|
|
|
|
|
|
|
LONG TERM LIABILITIES
|
|
|
|
|
|
|
|
|
|
Operating lease liability
|
|
|
1,616,553 |
|
|
|
1,725,073 |
|
|
Note payables, net of current portion
|
|
|
- |
|
|
|
1,418 |
|
|
|
|
|
|
|
|
|
|
|
|
Total long term liabilities
|
|
|
1,616,553 |
|
|
|
1,726,491 |
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
12,873,217 |
|
|
|
8,455,465 |
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and Contingencies (See Note 16)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
Common stock,
|
|
|
7,545 |
|
|
|
6,841 |
|
|
Additional paid-in capital
|
|
|
37,834,831 |
|
|
|
31,215,698 |
|
|
Deferred compensation
|
|
|
(107,334 |
) |
|
|
- |
|
|
Accumulated deficit
|
|
|
(35,117,185 |
) |
|
|
(28,746,939 |
) |
|
|
|
|
|
|
|
|
|
|
|
Total stockholders' equity
|
|
|
2,617,857 |
|
|
|
2,475,600 |
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
$ |
15,491,074 |
|
|
$ |
10,931,065 |
|
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
|
|
|
Three Months Ended |
|
|
Three Months Ended |
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
REVENUE
|
|
$ |
14,925 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
4,210,066 |
|
|
|
1,894,981 |
|
|
Research and development
|
|
|
357,073 |
|
|
|
91,263 |
|
|
Sales and marketing
|
|
|
111,350 |
|
|
|
7,661 |
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
4,678,489 |
|
|
|
1,993,905 |
|
|
|
|
|
|
|
|
|
|
|
|
OTHER INCOME (EXPENSES)
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
(361,870 |
) |
|
|
(1,175 |
) |
|
Other income
|
|
|
177,789 |
|
|
|
16,915 |
|
|
Change in fair value of derivative liabilities
|
|
|
1,129,769 |
|
|
|
- |
|
|
Accretion of debt discount
|
|
|
(250,969 |
) |
|
|
- |
|
|
Loss on conversion of convertible notes payable
|
|
|
(2,345,613 |
) |
|
|
- |
|
|
Realized gain on investments
|
|
|
446,324 |
|
|
|
- |
|
|
Unrealized loss on investments
|
|
|
(502,112 |
) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
Total other income (expenses)
|
|
|
(1,706,682 |
) |
|
|
15,740 |
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS BEFORE TAXES
|
|
|
(6,370,246 |
) |
|
|
(1,978,165 |
) |
|
|
|
|
|
|
|
|
|
|
|
PROVISION (BENEFIT) FOR INCOME TAXES
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS
|
|
$ |
(6,370,246 |
) |
|
$ |
(1,978,165 |
) |
|
|
|
|
|
|
|
|
|
|
|
NET LOSS PER SHARE:
|
|
|
|
|
|
|
|
|
|
Basic and diluted
|
|
$ |
(0.18 |
) |
|
$ |
(0.07 |
) |
|
|
|
|
|
|
|
|
|
|
|
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING:
|
|
|
|
|
|
|
|
|
|
Basic and diluted
|
|
|
36,167,200 |
|
|
|
29,721,248 |
|
CONDENSED STATEMENTS OF CASH FLOWS
For the Three Months Ended
|
|
|
2026 |
|
|
2025 |
|
||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
||
|
Net loss
|
|
$ |
(6,370,246 |
) |
|
$ |
(1,978,165 |
) |
|
Adjustments to reconcile net loss to net cash used in operating activities
|
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
1,043,789 |
|
|
|
1,348,245 |
|
|
Depreciation and amortization
|
|
|
56,214 |
|
|
|
7,391 |
|
|
Credit loss expense
|
|
|
300 |
|
|
|
- |
|
|
Operating lease liability - non-cash adjustment
|
|
|
739 |
|
|
|
- |
|
|
Change in fair value of derivative liability
|
|
|
(1,129,769 |
) |
|
|
- |
|
|
Loss on conversion of convertible notes payable
|
|
|
2,345,613 |
|
|
|
- |
|
|
Accretion of discount on convertible note payable
|
|
|
250,969 |
|
|
|
- |
|
|
Accretion of issuance costs on convertible note payable
|
|
|
119,018 |
|
|
|
- |
|
|
Realized gain on investments
|
|
|
(446,324 |
) |
|
|
- |
|
|
Unrealized loss on investments
|
|
|
502,112 |
|
|
|
- |
|
|
Changes in operating assets and liabilities
|
|
|
|
|
|
|
|
|
|
(Increase) decrease in
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
4,675 |
|
|
|
- |
|
|
Prepaid expenses
|
|
|
(90,224 |
) |
|
|
7,081 |
|
|
Other current assets
|
|
|
- |
|
|
|
1,412 |
|
|
Other assets
|
|
|
(213,554 |
) |
|
|
- |
|
|
Increase (decrease) in
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
43,916 |
|
|
|
(66,262 |
) |
|
Accrued expenses
|
|
|
952,486 |
|
|
|
133,627 |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
|
|
|
(2,930,286 |
) |
|
|
(546,671 |
) |
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
(220,346 |
) |
|
|
(2,832 |
) |
|
Proceeds from sales of investments
|
|
|
8,893,827 |
|
|
|
- |
|
|
Purchase of investments
|
|
|
(11,751,675 |
) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(3,078,194 |
) |
|
|
(2,832 |
) |
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock, net
|
|
|
- |
|
|
|
420,753 |
|
|
Taxes paid for shares withheld upon vesting of restricted stock units
|
|
|
(25,749 |
) |
|
|
- |
|
|
Proceeds from the exercise of warrants, net
|
|
|
- |
|
|
|
296,875 |
|
|
Repayments of note payables
|
|
|
(2,222 |
) |
|
|
(2,075 |
) |
|
Proceeds from issuance of convertible notes payable
|
|
|
10,000,000 |
|
|
|
- |
|
|
Debt issuance costs
|
|
|
(400,000 |
) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
9,572,029 |
|
|
|
715,553 |
|
|
|
|
|
|
|
|
|
|
|
|
NET INCREASE IN CASH AND CASH EQUIVALENTS
|
|
|
3,563,549 |
|
|
|
166,050 |
|
|
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
|
|
2,104,004 |
|
|
|
129,318 |
|
|
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS, END OF PERIOD
|
|
$ |
5,667,553 |
|
|
$ |
295,368 |
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
|
|
|
|
|
|
|
|
|
Cash paid for:
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$ |
1,064 |
|
|
$ |
321 |
|
|
Income taxes
|
|
$ |
- |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURE OF NONCASH INFORMATION
|
|
|
|
|
|
|
|
|
|
Common stock issued as payment of offering costs
|
|
$ |
- |
|
|
$ |
6,927,869 |
|
|
Common stock issued for deferred compensation
|
|
$ |
161,000 |
|
|
$ |
- |
|
|
Common stock issued for conversion of convertible notes payable
|
|
$ |
6,468,903 |
|
|
$ |
- |
|
|
Derivative liabilities reclassified as additional paid-in capital upon conversion of convertible notes payable
|
|
$ |
1,200,231 |
|
|
$ |
- |
|
|
Deferred offering costs recognized as additional paid-in capital upon financing drawdown
|
|
$ |
2,174,671 |
|
|
$ |
- |
|
SOURCE:
press release
